Quantum-Si (QSI) Long-Term Investments (2020 - 2026)

Quantum-Si's (QSI) quarterly Long-Term Investments came in at $63.0 million in Q1 2026, up 19.24% on a QoQ basis from $52.9 million in Q4 2025.

Quantum-Si (QSI) Long-Term Investments (2020 - 2026) Analysis & Trends

Quantum-Si (QSI) has 4 years of Long-Term Investments data on file, last reported at $63.0 million in Q1 2026.

On a quarterly basis, Long-Term Investments changed N/A year-over-year to $63.0 million in Q1 2026; TTM through Mar 2026 was $63.0 million, a N/A change from a year earlier, with the FY2025 full-year figure at $52.9 million, changed N/A from the prior year.
Long-Term Investments for Q1 2026 stood at $63.0 million, up from $52.9 million in the prior quarter.
Over the last five years, Long-Term Investments for QSI reached as high as $63.0 million in Q1 2026 and fell as low as $4.7 million in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Long-Term Investments (Qtr)
1	Abbott Laboratories	201.40 Bn	194.75 Bn	6.27 Bn	1.09 Bn
2	Stryker	122.29 Bn	119.41 Bn	3.81 Bn	-
3	Medtronic	105.01 Bn	96.40 Bn	6.41 Bn	-
4	Boston Scientific	64.81 Bn	63.59 Bn	3.61 Bn	-
5	Edwards Lifesciences	55.28 Bn	51.60 Bn	1.29 Bn	285.60 Mn
6	Dexcom	29.06 Bn	27.94 Bn	750.30 Mn	-
7	Koninklijke Philips	29.02 Bn	25.93 Bn	2.07 Bn	166.25 Mn
8	GE HealthCare Technologies	28.27 Bn	26.20 Bn	1.98 Bn	-
9	Smith & Nephew	25.80 Bn	25.22 Bn	-	121.00 Mn
10	Quantum-Si	171.01 Mn	43.67 Mn	74,000.00	63.02 Mn

Download Data